Treatment experience enzymbiotic in patients with obesity and dyslipidemia-Reference-Cited by-同舟云学术

Treatment experience enzymbiotic in patients with obesity and dyslipidemia

Published:2023-12-18 Issue:12 Volume: Page:111-119
ISSN:1682-8658
Container-title:Experimental and Clinical Gastroenterology
language:
Short-container-title:ECG

Author:

Khudyakova N. V.¹^ORCID,Khudiakov Yu. S.²^ORCID,Kotrova A. D.³^ORCID,Shishkin A. N.¹^ORCID,Varzin S. A.¹^ORCID,Sinitsa A. .⁴,Rejepova L. .¹^ORCID

Affiliation:

1. Saint-Petersburg University

2. PR «Natural Intelligence»

3. Municipal Polyclinic No. 32

4. Parusin GmbH

Publisher

LLC Global Media Technology

Reference24 articles.

1. Cicero A. F.G., Fogacci F., Bove M., Giovannini M., Borghi C. Impact of a short - term synbiotic supplementation on metabolicsyndrome and systemic inflammation in elderly patients: a randomized placebo-controlled clinical trial. European Journal of Clinical Nutrition. 2021;60(2):655-663. doi: 10.1007/s00394-020-02271-8

2. Solovuova O. I., Simanenkov V. I., Suvorov A. N., Ermolenko E. I., Shumihina I. A., Svirido D. A. The use of probiotics and autoprobiotics in the treatment of irritable bowel syndrome. Experimental and Clinical Gastroenterology. 2017;(7):115-120. (In Russ.)@@ Solov'eva O. I., Simanenkov V. I., Suvorov A. N., Ermolenko E. I., Shumikhina I. A., Svirido D. A. Ispol'zovanie probiotikov i autoprobiotikov v lechenii sindroma razdrazhennoi tolstoi kishki. Eksperimental'naya i klinicheskaya gastroenterologiya. 2017;7:115-120.

3. Lapinskii I. V., Serkova M. Yu., Bakulin I. G., Skalinskaya M. I., Avalueva E. B. Metabiotic based on metabolites of Bacillus subtilis for correction of gastrointestinal symptoms in patients with post-COVID syndrome. Medical alphabet. 2022;(35):8-14. (In Russ.) doi: 10.33667/2078-5631-2022-35-8-14.@@ Lapinskii I. V., Serkova M. Yu., Bakulin I. G., Skalinskaya M. I., Avalueva E. B. Vozmozhnosti ispol'zovaniya metabiotika na osnove metabolitov Bacillus subtilis dlya korrektsii gastrointestinal'nykh simptomov u patsientov s postkovidnym sindromom. Meditsinskii alfavit. 2022;(35):8-14. doi: 10.33667/2078-5631-2022-35-8-14.

4. Ruiz Sella S. R.B., Bueno T., de Oliveira A. A.B., Karp S. G., Soccol C. R. Bacillus subtilis natto as a potential probiotic in animal nutrition. Critical Reviews in Biotechnology. 2021;41(3):355-369. doi: 10.1080/07388551.2020.1858019.

5. Horie M., Koike T., Sugino S., Umeno A., Yoshida Y. J. Evaluation of probiotic and prebiotic-like effects of Bacillus subtilis BN on growth of lactobacilli. Journal of Applied Microbiology. 2018;64(1):26-33. doi: 10.2323/jgam.2017.03.002